Oman vs Saint Vincent and the Grenadines: Immunization, Hib3
Oman
99.0%
in 2024
Saint Vincent and the Grenadines
99.0%
in 2024
Oman rank
1st
Saint Vincent and the Grenadines rank
1st
Immunization, Hib3 over time
- Oman
- Saint Vincent and the Grenadines
How they compare
Oman currently reports 99.0% against 99.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 9 times across 22 shared years of data; in 2003 it was Oman ahead.
Oman ranks 1st and Saint Vincent and the Grenadines ranks 1st of 191 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 98.7% | 88.7% | 10.0% | Oman |
| 2010s | 98.8% | 98.0% | 0.8% | Oman |
| 2020s | 99.0% | 97.8% | 1.2% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Oman or Saint Vincent and the Grenadines?
- Oman, at 99.0% against 99.0% in Saint Vincent and the Grenadines as of 2024.
- What is the difference in immunization, hib3 between Oman and Saint Vincent and the Grenadines?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Saint Vincent and the Grenadines?
- 22 years are reported by both, from 2003 to 2024.
- How do Oman and Saint Vincent and the Grenadines rank globally for immunization, hib3?
- Oman ranks 1st and Saint Vincent and the Grenadines ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.